Major Review Finds Limited Benefit of Cannabis-Based Treatments for Psychiatric Conditions
A comprehensive review of cannabis-based treatments psychiatric conditions found minimal to no significant clinical benefit. This evidence highlights the limited efficacy of cannabis in psychiatric care. Clinicians should consider these findings when…
Medical cannabis isn’t an effective treatment for anxiety, depression or PTSD, new research shows
New medical cannabis mental health research shows insufficient efficacy for anxiety, depression, and PTSD. Despite growing patient interest, evidence does not support cannabis as an effective treatment. Clinicians should counsel patients on…
AM Policy Update: DEA Synthetic Opioids Schedule I Placement
The DEA synthetic opioids schedule I placement update on March 17, 2026, highlights key regulatory changes. This update covers multiple synthetic opioids classified under Schedule I. These changes impact controlled substance regulations and cannabis…
Full-Spectrum Cannabis Extract Chronic Pain Study Update
This AM Study Update covers the latest research on full-spectrum cannabis extract chronic pain treatment. The phase 3 trial of Cannabis sativa extract DKJ127 shows promising results for chronic low back pain. Clinicians can use this evidence to guide…
Cannabis Clinical Trials Mental Health Insights 2026
This AM News Update covers cannabis clinical trials mental health research from March 17, 2026. It highlights recent studies on cannabis efficacy and safety for mental disorders. The update emphasizes the need for rigorous dose-finding studies and…
Ohio Marijuana Law Overhaul Set to Take Effect; Petition Drive Aims to Repeal Changes – WBRC
Ohio marijuana law overhaul introduces significant regulatory changes impacting patient access and clinical counseling. The petition drive aims to repeal these changes, creating legal uncertainty. Clinicians must stay informed about Ohio marijuana law…
Cannabis Legal Enforcement Patterns in Medical Access 2026
This article reviews cannabis legal enforcement patterns and their impact on medical cannabis card access. It highlights the tension between expanding medical access and ongoing criminal penalties. Understanding these patterns is crucial for clinical…
Using Marijuana to Ease Anxiety or Depression? Science Shows the Evidence Isn’t There
Cannabis use for anxiety and depression is increasingly common, but current evidence does not support its efficacy. Research shows mixed or inconclusive results for cannabis in mood disorders. Clinicians should counsel patients on the lack of proven…
Two newly released analyses of existing research have found no evidence that marijuana is …
Recent analyses highlight that cannabis efficacy anxiety depression is not supported by sufficient evidence. Patients often self-medicate with marijuana despite lacking efficacy data. Clinicians should counsel patients on evidence-based treatments and…
Cannabis Shows Little Benefit for Most Mental Disorders, Data Review Finds
Current evidence shows cannabis mental health risk outweighs benefits for most psychiatric disorders. Despite patient interest, cannabis demonstrates minimal efficacy for anxiety and depression. Clinicians should counsel patients on limited benefits and…